Positive Phase 3 Results For Cannabis Drug Ignites Sector

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

GW Pharmaceuticals plc (GWPH) announced positive results this morning from a Phase 3 study of their cannabis drug Epidiolex® for the treatment Dravet syndrome, a rare and severe form of epilepsy in children, which resulted in a dramatic decrease in convulsive seizures assessed over the treatment period compared with placebo.

Read the entire press release on the company’s website, HERE.

Shares of GWPH opened up 100% over the previous close, and held to close up 120% on the day.

As a result of today’s exciting news for GWPH, several small cap stocks caught a boost of momentum, which has been the first sign of a sector wide move for cannabis related stocks in quite some time.

Among the most impressive were CBDS (Cannabis Sativa) which closed up more than 240% on the day, with all time record volume, at 1.535 per share, just off it’s session high of 1.60 at the close.

CANV (CannaVest Corp.) also made a very nice move today, adding to it’s already impressive 100% move over the past couple weeks, closing up more than 75% at .658, not far from the session high of .675.

Other notable moves in the sector include GRNH (GreenGro Technologies, Inc.) +53.74%, CBIS (Cannabis Science Inc.) 48.11%, and HEMP (Hemp, Inc.) +25.00%.

Keep a close eye on the entire cannabis sector tomorrow!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

PHOT Shares Soar 200%+ Following Relisting To OTCBB

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We hope all of you have been well during our recent down time, the OTC has been quite dull so far this year (to say the least(, relative to the past couple years, as the market has seen slowing liquidity with always rampant share dilution; which can be a deadly combo when it comes to OTC listed securities.

PHOT (GrowLife, Inc.) changed things up a bit today, announcing their relisting to the OTCBB following FINRA’s approval, after a massive fall from grace a couple years ago as one of the most widely held publicly traded cannabis-related companies, when shares were sent to the Grey Sheets following an SEC trading suspension.

PHOT‘s impressive milestone today caught the attention of many, as the stock traded nearly 23 million shares and closed up more than 223% at .055 per share from an open of .0179.

Shares closed just off the session high of .057, and could test the .074 weekly moving average (200 day) and if that proves weak, might test the .10 level.

Keep PHOT on close watch tomorrow.

 

We look forward to the OTC picking back up, and picking back up on our consistently profitable event-driven alerts!

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

TRTC Catapults Higher By Nearly 63% Following Our Heads Up!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

While turmoil shrouded the broader markets, our call on Terra Tech Corp. (TRTC) paid off massively as shares rose by 62.71% with nearly $3M exchanging hands, more than doubling yesterday’s volume.

With Terra Tech Corp. (TRTC), the writing was practically on the wall, given yesterday’s news and the aggressiveness in which shares were purchased, it would have been hard for it not to move higher today.

What was surprising, however, was the intensity that continued throughout today’s session that caused the stock to move far higher than our initial expectations.

Is it ever a bad thing to complain about making more than you suspected?

That question is rhetorical, but the stock quickly ran up to resistance we pointed out at it’s 200 day moving average early in the day, trading up to that level within the first hour.

After the stock collected itself, weeding out any short term traders, shares catapulted through the high at the time of .1285, and the rest is history…

TRTC closed at .178, up 62.71%, and traded higher the entire session.

It would have been hard to screw this trade up, unless you didn’t trade it at all!

Don’t forget to take profits – it’s possible the stock reaches .20 or more, but the risk vs. reward at this time is too great to consider holding (from our perspective).

Keep an eye on the stock for support at it’s old resistance near it’s 200MA for a potential bounce; a bounce from the .11-.12 range would be an ideal risk vs. reward setup moving forward.

We will be back with another quality, event-driven alert shortly!

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

Terra Tech Shares Surge Higher Following Merger Announcement

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We have been quiet this week for good reason – the OTC Market as a whole has had relatively nothing to talk about, and rather than recycle useless information, we are maintaining our focus of quality, event driven stocks. In a market like this, one must be selective, and quality vs. quantity is something we have always preached.

With that all being said, Terra Tech Corp. (TRTC), which most OTC traders who have been in the market for greater than a year would recognize, announced a definitive merger agreement this morning to acquire 100% of the outstanding shares of Black Oak Gallery, DBA: Blum Oakland.

Blum is a retail medical cannabis dispensary in Oakland with more than 42,000 registered patients, and has been in business since 2012, generating upwards of $14 million in non-GAAP revenue over the past 12 months.

Investors quickly and aggressively scooped up shares on the news, as the stock surged higher to close up by more than 23% with it’s highest volume traded in well over a year; an impressive feat to say the least.

With the kind of price action, and more importantly investor interest (volume wise), it’s very possible, in our opinion, TRTC moves higher towards it’s 200 day moving average of .129 over the next couple days.

If shares fail to hold the .10 level in this trend, we would consider that a breakdown to exit stage left, and will consider that a level of support moving forward.

Keep (TRTC) on top of your watch list for tomorrow following today’s impressive performance!

 

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

While Broader Markets Plunge, SBFM Keeps On Rising!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

This week has been tumultuous for broader markets to say the very least, with the Dow Jones down more than 900 points and the NASDAQ down more than 300 points, swings of -5%+ and -6% respectively, as pressure from China devaluing the yuan has made every global market  their prisoner.

As we have all come to know and realize through trading the OTC over the years, investors and traders alike could rather care less about what’s going on outside of their realm.

Look no further than Sunshine Biopharma (SBFM), which was on our watch list at the start of this week as we eyed the .015 level as support, and has now turned into a true double by crossing the .03 level today after coming back to the support we suspected it might.

Even at today’s close of .0255,  SBFM is up more than 96% this week, and considering what is going on elsewhere it would be very hard to complain with this kind of action.

The stock has been a traders dream to say the very least, offering multiple high percentage swings along it’s path upwards, and given the consistency of each dip in price being met with heavy buying, we’d be crazy to say (yet) that the trend is over.

Look for SBFM to retest the .02 level, where a dip below that price may offer another nice trading opportunity, and set up another favorable risk vs. reward scenario.

This has been the gift that keeps on giving, and although we believe that will inevitably come to an end (at least over the short term), there is still gas left in the tank, given the undeniable trend, to make another trade out of it before it’s all said and done.

Keep SBFM on your watch list again for tomorrow and don’t forget to take profits along the way!

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

TPAC Charges Ahead, Leaving Bears In It’s Wake

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We saw a lack of follow through out of our two on watch for today, but that doesn’t mean they won’t provide bounce opportunities over the short term, so we suggest continuing to keep them on watch. Better to buy on a dip than chase into a rip anyhow.

Our point of focus moves to TPAC (Trans-Pacific Aerospace Co.) for tomorrow, as shares continued on their amazing ascent today, closing up more than 54% and adding to the already impressive 1000%+ move since early December.

This impressive bull run has left any bear in sight long behind in it’s wake, as shares have moved from the .0005 range at the beginning of December up to new highs of .0057 today, and closed at .0054.

It’s an amazing feat to say the least, especially when you consider just how quick TPAC has achieved such gains, and at this point there is really no telling how high it might go.

As with any penny stock, shares have been very volatile, trading down to the same low it found support at yesterday of .0031 before closing significantly higher.

Due to the lack of follow through we saw in other names today, we wouldn’t suggest jumping the gun and entering right at tomorrow’s open, but if shares were to venture back below .004 it could be a good place to look at the stock for another potential bounce back.

If .0031 were to fail, one might expect the stock to continue lower before attempting to find another base to push higher from.

Keep TPAC (Trans-Pacific Aerospace Co.) on watch for tomorrow.

 

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

2016 Starts With A Splat, But Traders Thrive In A Volatile Market!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We hope all of you had a safe and very happy holiday season. We certainly did, and were reminded (as we are every year) how thankful we are to be in a position to live our passion and trade the market daily; something we all take for granted on a daily basis.

The New Year rang in with a sea of red, as U.S. markets felt the pressure from overseas following China’s Shanghai composite falling -6.86% which was exacerbated by the use of newly installed circuit breakers meant to curb panic. Those never really work as planned, do they?

U.S. markets recovered, relatively speaking, with the NASDAQ and the most popular ETF in the U.S., the SPDR S&P 500 (SPY), which tracks the S&P index, closing at session highs.

While OTC Markets remained unfazed (as usual) by the drama unfolding abroad and here at home, certain names moved higher with increasing volume.

Today’s standouts included Medbox, Inc. (MDBX) and Sunshine Biopharma (SBFM), which have both been hot topics in our absence over the past week.

Medbox, Inc. (MDBX) has made some exciting announcements over the past couple weeks, first announcing they entered into a business agreement to create a large U.S. source of CBD oil, and then (more importantly) added last week that they had reached an agreement with one of their primary lending sources to put a temporary restriction on converting shares through next month.

Shares of Medbox closed up 55.77% today, with a noticeable increase in trading volume, as more than 17.5 million shares exchanged hands between .02-.0415, and finished at .0405.

Watch for a potential move to the 50 day moving average of .047, or a more psychological level such as .05, and if support starts to form above those levels and another strong close follows, a move to the next resistance range near .075 could be in the works.

Sunshine Biopharma (SBFM) has also made smooth moves in our absence, following the announcement last week that they acquired all remaining worldwide patents for its ‘Adva-27a’ anti-cancer compound, and is up nearly 1000% since as a result of said news.

While shares seem overbought at current prices, the stock has been accumulated on each dip over the past week, and buyers could seek to push it higher before it even thinks of going lower.

Ideally, we would like to see support at the 200 day moving average of .015, and a potential push past .02 (or higher) again for a trade idea.

Keep both Medbox, Inc. (MDBX) and Sunshine Biopharma (SBFM) on close watch tomorrow for continued moves higher.

Lets make 2016 another great year filled with profitable trades that make sense.

Happy Trading & Happy New Year!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

TPIV Looks To Bounce Back Following Strong Fundamental Developments

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

We hope all of you are enjoying a beautiful weekend. Here, like almost everywhere else, it’s unusually warm for this time of the year, but hot is better than cold. Our main focus over the past few weeks, TPIV (TapImmune, Inc.), started the week off hot, reaching new highs of .97, but ended the week pretty cold after closing at .70.

Shares of TPIV are still up considerably from our initial heads up, and after the fundamental improvements announced by the company last week we expect shares to bounce back from here above .80 or more again soon.

The stock has had heavy support near it’s 50 day moving average since our coverage began, and we will look for that to be a point of major support should the .64 level (where it currently sits) comes into play.

Last week the company announced that they had received Orphan Drug Approval from the FDA for one of their vaccines, TPIV 200, in the treatment of ovarian cancer.

Read the full press release, HERE, for yourself.

We expect TPIV might have even more to share with investors over the coming weeks, which is even more reason why we think shares will bounce back over the short term.

If TPIV can go as far to break above it’s most recent high of .97, and breach the $1.00 level shortly after, we might see a true double from our multiple alerts near .60 over the past month, which would make for a very fine way to end the year.

Keep TPIV on top of your watch list for Monday!

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue trade up to 100,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time. We have no position at this time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

TPIV Closes Strong Following FDA Orphan Drug Designation

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

For those of you who have been following along the ride with us in TPIV (TapImmune, Inc.) over the past couple months, one of the key pieces of news we were looking for was released within the last 10 minutes of today’s session.

The company announced the FDA has granted Orphan Drug Designation (ODD) for it’s cancer vaccine TPIV 200 in the treatment of ovarian cancer.

Read the full press release, HERE, for yourself.

It wasn’t until less than 10 minutes before the closing bell the company released this news, which should make for an exciting morning Thursday given the company will also be presenting at the San Antonio Breast Cancer Symposium between 7:30-9:00AM EST.

We expect TPIV might have even more exciting news regarding a potential big pharma partnership within the next several weeks, but will reassess our point of view following tomorrow’s session.

If TPIV can break above it’s most recent high of .97, and breach the $1.00 level shortly after, we might see a true double from our multiple alerts near .60 over the past month, which would make for a fine way to end the year.

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue trade up to 100,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time. We have no position at this time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

TPIV Sliced Through Major Resistance, Closing Up 15%+ Today!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

TPIV (TapImmune, Inc.) has been the center of attention on our blog over the past couple months, and further proved why today following an exciting announcement before the open which set the precedent for the day.

The company announced their plans to present new data at the upcoming San Antonio Breast Cancer Symposium (SABCS) this upcoming Thursday, December 10th.

Shares battled major resistance early in the session between .75-.76, but once they broke through that level for good there was no looking back as the stock made it’s way all the way to .88, and closed the day up nearly 16% at .861 per share.

TPIV (TapImmune, Inc.) is also expecting Orphan Drug Designation Approval from the FDA over the short term as well as a potential Fast Track designation for their folate alpha receptor breast cancer vaccine.

We are excited for what the company might present Thursday and would suggest watching any potential dips in the stock between now and then.

Happy Trading!

Sign up-> NOW <-To Join Our E-mail List!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com

Please read our legal Disclaimer below:

We continue trade up to 100,000 shares of TPIV which we have purchased on the open market with our own money. We have no communication with the company nor any affiliates. We may add to this position or sell it entirely at any time. We have no position at this time.

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.